Skip to main content

Table 1 Correlation between the clinicopathological factors and expression of SNHG20

From: Increased long noncoding RNA SNHG20 predicts poor prognosis in colorectal cancer

Factors

Tumor low expression

(n = 53) N (%)

Tumor high expression

(n = 54) N (%)

P a

Sex

   

 Male

37 (69.8)

38 (70.4)

0.949

 Female

16 (30.2)

16 (29.6)

 

Age (years)

   

  < 65

25 (47.2)

26 (48.1)

0.919

  ≥ 65

28 (52.8)

28 (51.9)

 

Tumor location

   

 Colon

32 (60.4)

42 (77.8)

0.051

 Rectum

21 (39.6)

12 (22.2)

 

TNM

   

 I-II

30 (56.6)

20 (37.0)

0.043

 III-IV

23 (43.4)

34 (63.0)

 

T

   

 T1-T2

11 (20.8)

3 (5.6)

0.020

 T3-T4

42 (79.2)

51 (94.4)

 

N

   

 N0

30 (56.6)

30 (55.6)

0.913

 N1-N2

23 (43.4)

24 (44.4)

 

M

   

 M0

44 (83.0)

32 (59.3)

0.007

 M1

9 (17.0)

22 (40.7)

 

Gradeb

   

 G1-G2

46 (86.8)

40 (74.1)

0.098

 G3

7 (13.2)

14 (25.9)

 

CEA

   

  < 5 ng/mL

19 (35.8)

8 (14.8)

0.012

  ≥ 5 ng/mL

34 (64.2)

46 (85.2)

 
  1. Statistical significance is highlighted by bold font
  2. T depth of tumor, N lymph node, M distant metastasis, CEA carcino-embryonic antigen
  3. aTwo-sided chi-square test
  4. bGrade 1 and 2 stand for high or middle differentiated tumor, grade 3 stands for poorly differentiated tumor